Has Victoria Hull, PA received payments from drug or device companies?

Yes. Drug and device makers reported $7,696 in general payments to Victoria Hull, PA across 393 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Victoria Hull, PA did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Victoria Hull, PA come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Victoria Hull, PA

Physician Assistant · Columbia, MONPI 1376164616

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.5% of the total across 393 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by AbbVie at 26.6% of the total. Among physician assistant clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,696in general payments, 2019–2025

Across 393 payments — averaging $19.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$2K
Johnson & Johnson$2K
Novartis$1K
E.r. Squibb & Sons, L.L.C.$577
Lilly USA, LLC$520
Sanofi$355
plus $1K from 15 others

What the payments were for

Food & beverage$7,27395%
Education$4225%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	131	$2,046
Johnson & Johnson	72	$1,779
Novartis	56	$1,190
E.r. Squibb & Sons, L.L.C.	31	$577
Lilly USA, LLC	35	$520
Sanofi	13	$355
Sun Pharmaceutical Industries Inc.	11	$305
Pfizer	10	$202
Regeneron Healthcare Solutions, Inc.	6	$150
Amgen	5	$104
UCB, Inc.	4	$88
Fresenius Kabi USA, LLC	4	$71
Boehringer Ingelheim	2	$55
LEO Pharma Inc.	2	$47
Incyte Corporation	2	$43
Mallinckrodt Hospital Products Inc.	2	$41
Kyowa Kirin, Inc.	2	$32
Biofrontera Inc.	2	$32
Merz North America, Inc.	1	$23
Krystal Biotech Inc	1	$23
Galderma Laboratories, L.p.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Tremfya$247
LIBTAYO$103
Sotyktu$102
Skyrizi$100

How this compares

$7,696 in reported general payments places this provider in the 95th percentile of 1,380 physician assistant providers in Missouri.

See all physician assistant providers in Missouri →

Medicare billing

Part B allowed, 2024

$3,772

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Humira(Cf) PenAdalimumab	11	$74,927
Clobetasol Propionate	29	$1,899
Tacrolimus	12	$1,334
Fluorouracil	14	$876
Fluocinonide	18	$685
Ketoconazole	43	$676
Triamcinolone Acetonide	52	$496
Metronidazole	11	$473
Doxycycline Hyclate	28	$450
Hydrocortisone	30	$367
Mupirocin	32	$254
Cephalexin	13	$54
Amoxicillin	12	$23

Paid to pharmacies, not to this prescriber.

Other physician assistant in Columbia

Andrew JohnsonColumbia$9K
Sheridan BrownColumbia$7K
Jennifer DavissonKansas City$343K
Andrew BergLees Summit$245K
Sileen DowisKansas City$117K
Daniel BeckSikeston$114K
Amee RozancO Fallon$101K
Autumn WillsCape Girardeau$37K
Kimberly BrownSaint Louis$28K
Marc ReitznerSpringfield$24K

See the full list for Missouri →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →